title: Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.
authors.affiliation: Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. Matkins@bidmc.harvard.edu
authors.forename: Michael B
authors.initials: MB
authors.lastname: Atkins
authors.forename: Meredith
authors.initials: M
authors.lastname: Regan
authors.forename: David
authors.initials: D
authors.lastname: McDermott
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging
chemical_list: D016207:Cytokines; D016898:Interferon-alpha; D007376:Interleukin-2